These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 11152451

  • 1. Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer.
    Osman A, Niles EG, LoVerde PT.
    J Biol Chem; 2001 Mar 30; 276(13):10072-82. PubMed ID: 11152451
    [Abstract] [Full Text] [Related]

  • 2. Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation.
    Osman A, Niles EG, LoVerde PT.
    J Biol Chem; 2004 Feb 20; 279(8):6474-86. PubMed ID: 14630909
    [Abstract] [Full Text] [Related]

  • 3. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ, McGonigle S, Pearce EJ.
    Mol Biochem Parasitol; 2000 Nov 20; 111(1):131-42. PubMed ID: 11087923
    [Abstract] [Full Text] [Related]

  • 4. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P.
    EMBO J; 1997 Sep 01; 16(17):5353-62. PubMed ID: 9311995
    [Abstract] [Full Text] [Related]

  • 5. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, Imamura T.
    Biochem J; 2005 Mar 15; 386(Pt 3):461-70. PubMed ID: 15496141
    [Abstract] [Full Text] [Related]

  • 6. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.
    Souchelnytskyi S, Tamaki K, Engström U, Wernstedt C, ten Dijke P, Heldin CH.
    J Biol Chem; 1997 Oct 31; 272(44):28107-15. PubMed ID: 9346966
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
    Wicks SJ, Lui S, Abdel-Wahab N, Mason RM, Chantry A.
    Mol Cell Biol; 2000 Nov 31; 20(21):8103-11. PubMed ID: 11027280
    [Abstract] [Full Text] [Related]

  • 8. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
    Runyan CE, Schnaper HW, Poncelet AC.
    J Biol Chem; 2005 Mar 04; 280(9):8300-8. PubMed ID: 15613484
    [Abstract] [Full Text] [Related]

  • 9. A novel nuclear export signal in Smad1 is essential for its signaling activity.
    Xiao Z, Brownawell AM, Macara IG, Lodish HF.
    J Biol Chem; 2003 Sep 05; 278(36):34245-52. PubMed ID: 12821673
    [Abstract] [Full Text] [Related]

  • 10. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S, Ericsson J, Nishikawa J, Heldin CH, ten Dijke P.
    Nucleic Acids Res; 2000 Nov 01; 28(21):4291-8. PubMed ID: 11058129
    [Abstract] [Full Text] [Related]

  • 11. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K.
    J Cell Biol; 2001 Dec 10; 155(6):1017-27. PubMed ID: 11739411
    [Abstract] [Full Text] [Related]

  • 12. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC, de Caestecker MP, Schnaper HW.
    Kidney Int; 1999 Oct 10; 56(4):1354-65. PubMed ID: 10504488
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.
    Int Immunol; 2003 Dec 10; 15(12):1401-14. PubMed ID: 14645149
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C, Zhu NL, Tan RC, Ballard PL, Derynck R, Minoo P.
    J Biol Chem; 2002 Oct 11; 277(41):38399-408. PubMed ID: 12161428
    [Abstract] [Full Text] [Related]

  • 16. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T.
    Clin Cancer Res; 2001 Jun 11; 7(6):1618-26. PubMed ID: 11410498
    [Abstract] [Full Text] [Related]

  • 17. BF-1 interferes with transforming growth factor beta signaling by associating with Smad partners.
    Dou C, Lee J, Liu B, Liu F, Massague J, Xuan S, Lai E.
    Mol Cell Biol; 2000 Sep 11; 20(17):6201-11. PubMed ID: 10938097
    [Abstract] [Full Text] [Related]

  • 18. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S, Firth SM, Baxter RC.
    J Biol Chem; 2002 Mar 01; 277(9):7255-61. PubMed ID: 11751851
    [Abstract] [Full Text] [Related]

  • 19. Signal transduction of the TGF-beta superfamily by Smad proteins.
    Kawabata M, Miyazono K.
    J Biochem; 1999 Jan 01; 125(1):9-16. PubMed ID: 9880789
    [Abstract] [Full Text] [Related]

  • 20. Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway.
    Nakao A, Röijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin CH, ten Dijke P.
    J Biol Chem; 1997 Jan 31; 272(5):2896-900. PubMed ID: 9006934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.